Next Article in Journal
Measuring the Benefits of Mass Vaccination Programs in the United States
Next Article in Special Issue
Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines
Previous Article in Journal
Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death
Previous Article in Special Issue
Meningococcal Disease and Related Vaccinations: Knowledge, Attitudes, and Practices among Healthcare Workers Who Provide Care to Patients with Underlying High-Risk Medical Conditions
 
 
Article

Article Versions Notes

Vaccines 2020, 8(4), 560; https://doi.org/10.3390/vaccines8040560
Action Date Notes Link
article xml file uploaded 25 September 2020 13:34 CEST Original file -
article xml uploaded. 25 September 2020 13:35 CEST Update https://www.mdpi.com/2076-393X/8/4/560/xml
article pdf uploaded. 25 September 2020 13:35 CEST Version of Record https://www.mdpi.com/2076-393X/8/4/560/pdf
article html file updated 25 September 2020 13:36 CEST Original file -
article html file updated 22 July 2022 08:37 CEST Update https://www.mdpi.com/2076-393X/8/4/560/html
Back to TopTop